Shenzhen Neptunus Bioengineering Co., Ltd.

SZSE:000078 Stock Report

Market Cap: CN¥6.6b

Shenzhen Neptunus Bioengineering Management

Management criteria checks 3/4

Shenzhen Neptunus Bioengineering's CEO is Feng Zhang, appointed in Oct 2019, has a tenure of 5.25 years. directly owns 0.051% of the company’s shares, worth CN¥3.33M. The average tenure of the management team and the board of directors is 4.6 years and 5.3 years respectively.

Key information

Feng Zhang

Chief executive officer

CN¥4.2m

Total compensation

CEO salary percentagen/a
CEO tenure5.3yrs
CEO ownership0.05%
Management average tenure4.6yrs
Board average tenure5.3yrs

Recent management updates

Recent updates

Is Shenzhen Neptunus Bioengineering (SZSE:000078) A Risky Investment?

Dec 18
Is Shenzhen Neptunus Bioengineering (SZSE:000078) A Risky Investment?

Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Revenues Are Not Doing Enough For Some Investors

Oct 28
Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Revenues Are Not Doing Enough For Some Investors

Here's Why Shenzhen Neptunus Bioengineering (SZSE:000078) Is Weighed Down By Its Debt Load

Jul 15
Here's Why Shenzhen Neptunus Bioengineering (SZSE:000078) Is Weighed Down By Its Debt Load

There Is A Reason Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Price Is Undemanding

Jun 07
There Is A Reason Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Price Is Undemanding

Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Share Price Is Matching Sentiment Around Its Revenues

Mar 05
Shenzhen Neptunus Bioengineering Co., Ltd.'s (SZSE:000078) Share Price Is Matching Sentiment Around Its Revenues

CEO

Feng Zhang (52 yo)

5.3yrs

Tenure

CN¥4,240,000

Compensation

Mr. Feng Zhang has been an Executive Chairman and Compliance Officer of Shenzhen Neptunus Interlong Bio-Technique Company Limited since June 25, 2011. Mr. Zhang serves as an Executive President of Shenzhen...


Leadership Team

NamePositionTenureCompensationOwnership
Feng Zhang
Vice Chairman of the Board & President5.3yrsCN¥4.24m0.051%
CN¥ 3.3m
Da Kai Shen
Financial Director18.7yrsCN¥2.01m0.057%
CN¥ 3.8m
Yi Fei Zhang
Executive VP & Director2.3yrsCN¥2.05mno data
Rui Jin
VP & Non-Independent Director2.3yrsCN¥1.45mno data
Xiao Wang
Vice President4.6yrsCN¥1.20mno data
Shuangcheng Yang
Vice President5.3yrsCN¥1.16m0.095%
CN¥ 6.3m
Xiaoming Shi
Vice President5.3yrsCN¥1.10m0.26%
CN¥ 17.0m
Yunlei Wang
VP & Board Secretary2.3yrsCN¥677.50kno data
Ge Jin
Vice President2.3yrsCN¥119.30kno data

4.6yrs

Average Tenure

53yo

Average Age

Experienced Management: 000078's management team is considered experienced (4.6 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Feng Zhang
Vice Chairman of the Board & President15.1yrsCN¥4.24m0.051%
CN¥ 3.3m
Da Kai Shen
Financial Director5.3yrsCN¥2.01m0.057%
CN¥ 3.8m
Yi Fei Zhang
Executive VP & Director2.3yrsCN¥2.05mno data
Rui Jin
VP & Non-Independent Director2.3yrsCN¥1.45mno data
Si Min Zhang
Non-Independent Chairman of the Board32.1yrsCN¥150.00k0.13%
CN¥ 8.5m
Hanshu Che
Non-Independent Director5.3yrsCN¥150.00kno data
Xingquan Wang
Shareholder Supervisor5.3yrsno datano data
He Huang
Chairman of the Supervisory Board5.3yrsno datano data
Hua Zhang
Independent Director2.3yrsCN¥150.00k0.33%
CN¥ 21.5m
Huanjun Wang
Independent Director2.3yrsCN¥25.60kno data

5.3yrs

Average Tenure

56yo

Average Age

Experienced Board: 000078's board of directors are considered experienced (5.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 21:12
End of Day Share Price 2025/01/07 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shenzhen Neptunus Bioengineering Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Zhouyu DengBOCI Research Ltd.
Zhouyu DengGuosen Securities Co., Ltd.